Proof of Concept (POC) in Patients With Ischaemic Stroke

NCT01808261 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

134

Enrollment

INDUSTRY

Sponsor class

Stopped This study was terminated for futility.

Conditions

Cerebrovascular Accident

Interventions

DRUG: GSK249320 100/mg
DRUG: Placebo

Sponsor

GlaxoSmithKline